Overall Status

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

NantCell, Inc. (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

biospecimen collection (1)

gi-6301 placebo (1)

gi-6301 vaccine (yeast- brachyury) (1)

ipilimumab (1)

nivolumab (1)

radiotherapy (1)

wgt3x-bt actigraph (1)

Study Documents

Intervention Type

biological (2)

device (1)

other (1)

procedure (1)

radiation (1)

Funder Type

Industry (1)

NIH (1)

Study Type

Interventional (2)

chordoma

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting

Acinar Cell Carcinoma
+93 more

Biospecimen Collection
+2 more

Birmingham, Alabama
+998 more

Aug 23, 2022

Chordoma Trial run by the (other, biological, radiation, device)

Unknown status

Chordoma

GI-6301 Placebo
+3 more

Bethesda, Maryland

NIH Clinical Center

Oct 22, 2019